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Résumé 
Alors que le système nerveux sympathique a un rôle bien établi dans la régulation de 
la pression artérielle, l'influence de la fonction ou dysfonction du système 
parasympathique sur la pression artérielle n'est pas évidente, en particulier à long 
terme. Nous avons testé l'hypothèse que l'inhibition chronique du système 
parasympathique a un effet persistant sur la pression artérielle (PA), la fréquence 
cardiaque (FC) et la variabilité de la pression artérielle (VPA). Des rats de type 
Sprague Dawley ont été instrumentés pour monitoring de la pression artérielle 22h par 
jour par télémétrie et abrités dans des cages métaboliques. Après guérison de 
l'intervention et après une période contrôle de référence, de la scopolamine methyl 
bromide (SMB), un antagoniste muscarinique périphérique, a été perfusé i.v. pendant 
12 jours. Le tout fut suivi d'une période de récupération de 10 jours. La SMB a 
entraîné une augmentation rapide de la PA de 98±2 mmHg à un maximum de 108±2 
mmHg le deuxième jour de perfusion de la SMB puis la PA s'est stabilisée à une 
valeur plateau de +3±1 mmHg au dessus de la valeur contrôle (P < 0.05). Après l'arrêt 
de la perfusion de SMB, la PA moyenne a diminué de 6±1 mmHg. La FC a augmenté 
immédiatement et est restée significativement au dessus de la valeur contrôle le dernier 
jour de la perfusion de SMB. La SMB a également induit une diminution de la 
variabilité à court terme de la FC (au sein d'intervalles de 30 minutes) et une 
augmentation de la variabilité à court terme et à long terme (entre intervalles de 30 
minutes) de la PA. Ces données suggèrent que l'inhibition muscarinique périphérique 
chronique conduit à une augmentation modeste mais persistante de la PA, FC et VP A, 
qui sont des facteurs de risque cardiovasculaires connus. 
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doi: 1O.l152/ajpheart.00326.2007 .-Whereas the sympathetic nervous 
system has a well-established raie in blood pressure (BP) regulation, 
it is not clear whether long-term levels of BP are affected by 
parasympathetic function or dysfunction. We tested the hypothesis 
that chranic blockade of the parasympathetic nervous system has 
sustained effects on BP, heart rate (HR), and BP variability (BPV). 
Sprague-Dawley rats were instrumented for monitoring of BP 22-h 
per day by telemetry and housed in metabolic cages. After the rats 
healed from surgery and a baseline contra! period, scopolamine 
methyl bramide (SMB), a peripheral muscarinic antagonist, was 
infused intravenously for 12 days. This was followed by a 10-day 
recovery period. SMB induced a rapid increase in mean BP from 98 ± 
2 mmHg to a peak value of 108 ± 2 mmHg on day 2 of the SMB 
infusion and then stabilized at a plateau value of +3 ± 1 mmHg 
above contrai (P < 0.05). After cessation of the infusion, the mean BP 
fell by 6 ± l mmHg. There was an immediate elevation in HR that 
remained significantly above contrai on the last day of SMB infusion. 
SMB also induced a decrease in short-term (within 30-min periods) 
HR variability and an increase in both short-term and long-term 
(between 30-min periods) BPV. The data suggest that chranic periph-
eral muscarinic blockade leads to modest, but sustained, increases in 
BP, HR, and BPV, which are known risk factors for cardiovascular 
morbidity. 
blood pressure; autonomie nervous system; parasympathetic nervous 
system; blood pressure variability 
THE AUTONOMIC NERVOUS SYSTEM maintains cardiovascular ho-
meostasis through the opposing effects of its parasympathetic 
and sympathetic divisions on cardiac performance and through 
a predominantly sympathetic contrai of the vasculature. 
Whereas a sympathetic effect on blood pressure (BP) regula-
tion is well established (6), there is also evidence of an 
involvement of the parasympathetic nervous system in hyper-
tension. This was first suggested by Julius et al. (12) on the 
basis of acute pharmacological experiments in young individ-
uals with borderline hypertension and a hyperkinetic circula-
tion. Subsequent studies have shown an attenuation of the 
parasympathetic contrai of heart rate (HR) in hypertension (33) 
and in a number of conditions predisposing to hypertension 
such as ageing (27), obesity (l, 31), diabetes mellitus (3), 
chranic renal failure (2), and physical inactivity (24). However, 
it is not clear whether parasympathetic dysfonction may affect 
basal BP levels or exacerbate the hypertensive state. In addi-
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tion, since vagal dysfonction impairs the barareflex contrai of 
HR, parasympathetic dysfonction could pramote an increase in 
BP variability (BPV) (7), which has been shown to be an 
independent cardiovascular risk factor (9). 
The purpose of the present study was to test the hypothesis 
that sustained blockade of the parasympathetic system would 
lead to increased BP and BPV. To this end, we investigated the 
effects of a 12-day administration of scopolamine methyl 
bramide (SMB) in rats instrumented for monitoring of BP by 
telemetry. SMB, a quaternary derivative of scopolamine, was 
chosen because it is a muscarinic antagonist that does not 
readily cross the blood-brain barrier (4) and thus avoids po-
tential confounding effects of central muscarinic antagonism 
such as increased parasympathetic tone (18). 
METHODS 
Animal preparation. Male Sprague-Dawley rats (10-12 wk old, 
weighing ~390-400 g) supplied by the R. Janvier Center (France) 
were used in this study. All protocols were approved by the State 
Animal Committee. The rats were instrumented (under pentobarbital 
anesthesia, 60 mg/kg ip) with a BP telemeter (mode! TAI l-PA-C40, 
Data Sciences International) for monitoring of aortic BP as described 
previously (32). A catheter was also inserted in the left jugular vein 
and connected to a syringe pump via a single channel swivel as 
described previously (35), for continuous intravenous infusion of 
isotonie saline (10 µ!/min) starting on the day of surgery and main-
tained throughout the experimental study. The rats were housed in 
individual Plexiglas cages equipped for 24-h urine collection. The 
cages were in a quiet air-conditioned room (-21 °C) with a 12-h: 12-h 
light-dark cycle. 
Continuous hemodynamic monitoring by telemetJ)'. Each cage was 
equipped with one RMC-1 receiver connected to a calibrated analog 
adapter (RllCPA) and to an APR-1 barometric pressure reference 
device. Ali devices were manufactured by Data Sciences Interna-
tional. The telemetered analog pressure signal was sampled at 500 Hz 
for 5-s periods every 30 s, 24 h a day and processed by customized 
algorithms for beat-to-beat analysis to extract mean arterial pressure 
(MAP), systolic and diastolic blood pressures (SBP, DBP, respec-
tively), HR, rise time (time to reach peak SBP from the previous DBP 
point), and maximum rate of change of arterial pressure (dPaldt) ( 17). 
Telemetry probes were calibrated before implantation and atler re-
moval in a sealed pressure chamber at 0 and 200 mmHg, and pressure 
values were linearly corrected according to calibration values (29). 
Data were analyzed from 10:00 AM to 8:00 AM the next morning. 
The period between 8:00 AM and 10:00 AM was used for daily 
maintenance and was omitted from the analysis. 
The computer program separated the 22-h data set into a series of 
44 half-hour periods. The standard deviation (SD) of BP (for both 
MAP and SBP) were calculated for each half-hour period. The mean 
The costs of publication of this mticle were defrayed in pait by the payment 
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SD of BP was used as a measure of the short-term variability of BP, 
i.e., the extent of the variation in BP within half-hour periods (19, 30). 
In addition, we also calculated the SD of the 44 half-hourly mean BP 
values and used the SD as a measure of the long-term variability of 
BP, i.e., the extent of the variation in BP between half-hour periods 
( 19, 30). Finally, the SD of ail 2,640 daily samples was also computed 
as an index of overall 22 h BPV. Similar calculations were performed 
to calculate the short- and long-term HR variability. It should be noted 
that the SD of HR within half-hour periods does not represent 
beat-to-beat HR variability but the 30s-to-30s variability of HR. It is 
thus labeled "short-term" HR variability. 
Experimental protocol. In ail rats, experimental measurements 
included measurement of BP and HR 22 h a day and monitoring of 
daily food, water, and sodium intakes, urine output, and sodium and 
potassium excretions. Food and water intake were determined by 
differential weighing (precision at 0.1 g). Urine was collected in a 
graduated container. Urinary sodium and potassium concentrations 
were determined by ftame photometry (mode! IL 943). All animais 
had free access to tap water and were fed with a fi xed am ou nt of 20 g 
(slightly below the normal ad libitum intake) of standard rat chow per 
day to ensure a fixed sodium intake (a total of about 4 mmol/day, 
including 2.2 mmol/day via the infusion). 
In seven rats that were successfully instrumented (10.7 ± 0.2 wk 
old, weighing 396 ± 14 g), a SMB (Sigma, Switzerland) intravenous 
infusion was started after at least 12 days after the rats recovered from 
surgery and an additional contrai period of 4 days. SMB was infused 
for 12 days at increasing rates (0.3, 0.6, and 1.2 µg·kg- 1·min- 1 iv, 
4 days at each dose, labeled as periods 1, 2, and 3). The progressive 
increase in the SMB-infusion rate was chosen to ensure sustained 
muscarinic blockade, since pilot studies in which SMB was infused at 
the single dose of 0.3 µg· kg- 1 • min- 1 for 10 days showed a higher 
BP during the first 4 days of infusion (approximately + 10 mmHg) 
than during the following days (approximately +5mmHg). The SMB 
infusion was followed by a 10-day recovery period to test the 
reversibility of the experimental changes. Ail solutions (SMB or 
vehicle saline) were prepared aseptically and infused through a 
0.22-µm Millipore filter. 
Because BP and HR are known to exhibit a small spontaneous 
negative drift after surgery, a group of eight rats were submitted to the 
same surgical procedures (telemetry, intravenous infusion) and 
housed in identical cages to analyze the changes in BP and HR 
occurring during vehicle time-control infusion from day 9 after 
surgery (when the telemeter battery was turned on) up to 28 days after 
surgery. In two rats, the arterial BP signal could not be used for 
computation of MAP due to a large and unstable offset drift but was 
adequate for the computation of HR. The rats were studied up to 4 wk 
after surgery to quantify the spontaneous drift of the 22-h average of 
BP and HR. 
Statistical analysis. Each rat served as its own contrai, i.e., the 
effects of SMB infusion were compared with the average of the 4 
contrai days preceding SMB infusion. Statistical analysis was per-
formed by repeated measures ANOV A with the InStat statistical 
package (GraphPad Software). Experimental and contrai values were 
compared using Dunnett's multiple comparison test. Changes were 
considered significant if P < 0.05. Values are expressed as 
means ± SE. 
RESULTS 
SMB induced a rapid increase in mean, systolic and diastolic 
pressures, and HR (Fig. 1). MAP peaked on day 2 of the SMB 
infusion at + 10.5 ± 0.7 mmHg above a contra! value of 
97.9 ± 1.9 mmHg. The initial increase in MAP was attenuated 
over the next few days but MAP remained significantly ele-
vated at a plateau value of +2.9 ± 0.7 mmHg (P < 0.05) 
during the last 4 days of SMB (period 3), as shown in Table 1. 
On cessation of SMB infusion, MAP fell by 5.9 ± 0.7 mmHg 
(day 2 of recovery) and stabilized at 2.6 ± 1.1 mmHg below 
contra! value during the last 4 days of the recovery period 
(days 7 to 10 after SMB cessation). 
HR underwent an immediate increase with SMB infusion, 
peaking on the first day at + 52 ± 5 beats/min above the 
contra! value of 345 ± 8 beats/min. HR then tended to 
decrease pragressively but remained significantly above con-
tra! at +22 ± 5 beats/min by the last day of SMB infusion (day 
12). After cessation of the SMB infusion, HR fell by 36 ± 4 
beats/min (day 2 of recovery). During the final 4 days of the 
recovery period, HR reached a value of 318 ± 7 beats/min, i.e., 
27 ± 6 beats/min below the contra! level. 
Rats infused with vehicle infusion showed a small decrease 
in MAP by 3.0 ± 0.9 mmHg from 97.7 ± 1.1 mmHg (average 
of days 9-12 postsurgery) to 94.7 ± 1.0 mmHg (average of 
days 25-28), with most of the decrease (2.5 ± 1.1 mmHg) 
occurring during the first 20 days after surgery. HR showed a 
larger decrease of 31 ± 5 beats/min from a contra! value of 
361 ± 9 beats/min (average of days 9-12 postsurgery), with 
most of the decrease (22 ± 5 beats/min) occurring during the 
first 20 days after surgery. Subtracting the average daily 
negative drift of BP and HR observed in time-contral rats 
(using postsurgery days 13-16 as the contrai period) from 
individual values of experimental rats, we estimate the actual 
effects of SMB on MAP and HR in experimental rats to 
amount to 10.2 ± 0.4, 5.2 ± 0.7, and 5.5 ± 0.7 mmHg for 
periods 1, 2, and 3, respectively, and to 60 ± 5, 53 ± 4, and 
47 ± 4 beats/min for the same periods. 
Daily values of pulse pressure (PP), maximum dP,/dt, and 
rise time in SMB-infused rats are shown in Fig. 2. Changes F2 
from contrai values are summarized in Table 1. PP and max-
imum dP af dt were significantly higher only during the first few 
days of infusion (on day 3, PP peaked at +3.5 ± 0.7 mmHg 
above the contrai value of 22.8 ± 1.4 mmHg and maximum 
dPaldt peaked at +840 ± 216 mmHg/s above a contra! value 
of 5,062 ± 306 mmHg/s). Rise time was significantly 
shorter during days 1-4 (period 1) and 5-8 (period 2) and 
tended to remain shorter during the last 4 days of SMB 
infusion (period 3). 
Daily values of short-term and long-term MAP and HR 
variabilities are shown in Fig. 3. SMB induced a progressive FJ 
increase in both short-term ( + 16%, last 4 days of SMB 
infusion) and long-term ( + 36%) MAP variabilities, which 
reverted pragressively to contra! values on cessation of the 
SMB infusion. Interestingly, the changes in long-term variabil-
ity were slower to appear and also to disappear. The increase in 
BP variability was significant for both MAP and SBP and for 
ail three indexes of variabilities (within 30 min SD , between 
30 min SD, and overall 22 h SD), as shown in Table 2. SMB T2 
also lead to a marked (-43%) and sustained decrease in 
short-term HR variability (HRV). In contrast, the decrease in 
long-term HRV was only transient (-25% on day 2). 
Total water intake and urinary output tended to increase 
pragressively during SMB infusion, as shown on Fig. 4 and F4 
were significantly higher during the last 4 days of infusion 
(water intake: + 7.2 ml from a contrai value of 37.8 ± 1.1 
ml/day; urine output: +8.6 ml from contrai value of24.7 ± 0.7 
ml/day). Both variables returned slowly toward contra! during 
the recovery period. Changes occurred in parallel and, as a 
consequence, daily water balance remained unaltered. In 3 of 7 
rats, food intake (fixed at a maximum of 20 g/day) decreased 
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~lightly on day 2 of SMB infusion but was back to normal 
,thereafter. This explains the transient decrease in sodium and 
potassium intakes during day 2. In these three rats the non-
:ingested sodium of day 2 was compensated on the next day by 
supplementing food with an estimated equivalent of sodium 
'chloride. Sodium and potassium balances remained stable over 
the following days. 
DISCUSSION 
Whereas numerous studies have reported the cardiovascular 
ieffects of acute parasympathetic inhibition, we are not aware of 
any published study of the effects of more sustained parasym-
;pathetic blockade on hemodynamic fonction. The main finding 
of our study is that chranic peripheral muscarinic blockade 
leads to significant hemodynamic alterations, including sus-
tained elevations in BP, HR, and BPV. 
9 MAP 
6 SBP 
\J DBP 
20 25 
Fig. 1. Effects of a 12-day scopolamine methyl 
bromide (SMB) infusion on mean arterial pressure 
(MAP), systolic blood pressure (SBP), and diastolic 
blood pressure (DBP), and on heart rate (bpm, beats/ 
min). 
The effect on BP was most pranounced during the first 3 
days of muscarinic inhibition, with a peak increase in SBP, 
MAP, and DBP of more than 10% during day 2 of SMB. 
Although BP tended to return toward contral level over the 
following few days, BP remained significantly elevated during 
the last 4 days of SMB infusion as shown in Table 1, a 
conclusion also supported by the off transient in BP when the 
infusion was halted. The chranic SMB-induced effect on MAP 
amounted to a 3-6% increase, depending whether its effects 
are compared with the initial contrai period (3%) or the final 
recovery period (6%). 
The partial recovery of blood pressure during SMB infusion 
occurred despite evidence of the continued effectiveness of 
muscarinic blockade by SMB. HR, which initially increased by 
as much as 15% above contrai value, remained elevated by 
11 % on the last day of SMB infusion (based on the size of the 
AJP-Heart Circ Physiol •VOL 293 • SEPTEMBER 2007 • www.ajpheart.org 
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Table 1. Changes in hemodynamic values when compared with control levels 
Variable Period 1 Peri(}(/ 2 PeriOl! J Recovery 
SBP, mmHg 9.3±0.5t 3.5±0.9* 3.3:±: 1.1 * -2.8:±: 1.6 
MAP, mmHg 8.2±0.4t 3.3:±:0.7t 2.9±0.7* -2.6:±: 1.1 * 
DBP, mmHg 6.7±0.5t 2.9±0.7* 2.5±0.5* -2±0.9 
HR, beats/min 47±5t 35±4t 24±4t -27±6t 
PP, mmHg 2.6±0.7* 0.7±0.8 0.8:±: 1 -0.8:±: 1.5 
Max dPa/dt, mmHg/s 579:±: 184* 185:±: 163 66±264 -138±260 
Rise time, ms -1.7±0.2* -1.3±0.4* -1.0±0.4 0.2:±: l 
Values are means :±: SE (11 = 7 rats) computed as changes from control levels [last 4 days before starting scopolamine methyl bromide (SMB) infusion]. SBP, 
systolic blood pressure; MAP, mean arterial pressure; DBP, diastolic blood pressure; HR, heatt rate; PP, pulse pressure; Max dP,/dl, maximal rates of mterial 
pressure change. Periods /, 2, and 3 correspond to days 1-4, 5-8, and 9-12, respectively, of SMB infusion. Recovery corresponds to days 7-10 after cessation 
of SMB infusion. *P < 0.05 and tP < 0.01 vs. control period (Dunnett's). 
off transient, day 2 of recovery). The attenuation of the "short-
term" HR variability was even more dramatic, responding 
promptly at the onset and end of SMB infusion and not 
wavering throughout the 12-day infusion period. Combined 
with the observation that doubling the SMB dosage on days 
5-8 (period 2) and again on days 9-12 (period 3) failed to 
cause further alterations in HR, "short-term" HR variability, or 
any other measured parameter, our data suggest that the SMB 
infusion provided an effective and sustained blockade of car-
diac muscarinic receptors. 
The values of BP and HR during days 7-10 of the recovery 
period (-2.6 ± 1.1 mmHg and -27 ± 6 beats/min below 
contrai values for MAP and HR, respectively) are consistent 
with a moderate spontaneous decrease in hemodynamic values 
30 
25 
20 
often observed in chronic experiments after a surgical proce-
dure. Indeed, in a group of vehicle-infused rats instrumented in 
a similar way, there was an average decrease in MAP and HR 
of 3% and 8%, respectively, from days 9-12 after surgery to 
days 25-28. This slow decrease in vehicle-infused animais, 
possibly related to the graduai disappearance of expected 
postsurgery inflammatory reactions, strengthens our findings in 
SMB-infused rats that the significant increases in MAP and HR 
associated with long-term SMB infusion are not due to a slow 
positive baseline drift but represent a real phenomenon. 
Indeed, after the negative drift occurring in time-control 
animais was corrected, the estimated chronic effects of SMB 
amounted to a 6% increase in MAP and a 13% increase in 
HR (period 3). 
o~~~~~--ri'--~~--,~~~~.---~-+-~-.~~~--,.--~~--, 
Fig. 2. Effects of a 12-day SMB infusion on pulse pressure, 
maximum arterial pressure change rate (dP,/dl) and rise 
time. 
....... 
1/) 
.§. 
°' e j:: 
°' 1/) ~ 
42 
40 
38 
36 
0 
-5 0 5 10 
Time (Days) 
AJP-Heart Circ Pliysiol •VOL 293 • SEPTEMBER 2007 • www.ajpheatt.org 
15 20 25 
1 tapraid4/zh4-ahea/zh4-ahea/zh400907/zh47663d07a 1 tillotsj 1 S-3 1 6/19/07 1 8:32 1 MS: H-00326-2007 l lni: 09/km/ss 1 
BLOOD PRESSURE AND CHRONIC PARASYMPATHETIC BLOCKADE H5 
[!~~~~l~L~!t~ ~El_ mfuSlQ._"1~~~-
~ 8 1 1 8 _LQ.lt L 1 1 1 ~ 1 1 1 1 1 1 :.ë 1 1 1 1 1 1 
:.ë 1 1 m 7 1 
1 
7 1 1 
·;: Cil 1 1 1 1 m 1 ·;: 1 1 
> ~ 1 1 6 6 1 1 o. 1 
<( o. 1 1 
:E <( 1 1 
E 5 :::E 5 1 1 E 1 ... 1 Cl) ... 1 
"i' Cl) 
t:: 4 "i' 4 
0 C'l 
.c c: (/) 0 
3 ..J 3 
32 32 
~ 30 ~ 30 :.ë 28 28 m :a 
·;: 26 Cil 26 m ·;: 
> 24 Cil 24 0::: > 
::c 22 0::: 22 
E ::c 
... 
20 E 20 Cl) 18 ... 18 
"i' Cl) 
t:: 16 "i' 16 0 C'l 
.c 14 c: 14 (/) 0 
12 
..J 
12 
-5 0 5 10 15 20 25 -5 0 5 10 15 20 25 
Time (Days) Time (Days) 
Fig. 3. Effects of a 12-day SMB infusion on short-term and long-term MAP and heart rate (HR) variabilities. The time course of shmt-term and long-term SBP 
variabilities was very similar to the time course of MAP variabilities and is therefore not shown. 
Although our experimental approach (recording throughout 
the day, with animais left undisturbed as muchas possible) did 
not allow a more precise determination of the mechanisms 
underlying the SMB-induced increase in BP, at least three 
factors could be involved: 1) an increase in cardiac output (CO) 
due to a primary increase in HR and/or stroke volume; 2) an 
increase in peripheral vascular resistance; and 3) an altered 
ability of the kidney to excrete sait and water. 
For the first factor, while an increase in HR is expected 
initially to increase CO, stroke volume tends to fall with time 
and changes in HR per se may not lead to sustained increases 
in CO (8). However, a combination of increased HR and 
contractility could potentially cause a larger increase in CO. 
Tachycardia alone is expected to decrease PP and maximum 
dP,/dt as shown in heart-pacing experiments (26). ln our 
experiments, the observed increases (and the lack of decreases) 
in PP and maximum dPa/dt and the decrease in rise time are 
consistent with an increase in cardiac contractility during the 
SMB infusion, although we cannot exclude an effect of SMB 
to decrease arterial distensibility. 
For second factor, muscarinic blockade could promote va-
soconstriction. There is, however, little vascular parasympa-
thetic innervation to be blocked except for sparse specializecl 
circulations (33), but there is evidence for a local release of 
acetylcholine (ACh) by enclothelial cells themselves. The pres-
ence of choline acetyltransferase, the enzyme responsible for 
the synthesis of ACh, has been shown in cerebral microvascu-
lar endothelial cells of rats (20) and pigs ( 11), as well as in 
bovine caroticl artery endothelial cells (13). Milner et al. (16) 
couic! demonstrate a local release of ACh in isolatecl human 
umbilical vein endothelial cells, which is triggerecl by shear 
stress. Release of ACh by culturecl endothelial cells prepared 
Table 2. Short-tenn (within 30 min), long-term (between 30 min), and overall (22 h) SD of SEP and MAP 
Variable Control Peri()(/] Period 2 Peri(}(/] Recovery 
SBP 
Short-terrn SD, mmHg 4.9±0.3 5.6±0.2* 5.9±0.2t 5.7±0.2t 4.8±0.2 
Long-tenn SD, mmHg 4.5±0.3 5.0±0.3 5.9±0.4t 6.3±0.6t 4.9±0.4 
Overall SD, mmHg 6.6±0.3 7.5±0.2* 8.3±0.4t 8.5±0.5t 6.9±0.4 
MAP 
Short-tenn SD, mmHg 4.6±0.3 5.1±0.2* 5.4±0.2t 5.3±0.lt 4.5±0.2 
Long-tenn SD, mmHg 4.1±0.3 4.5±0.2 5.3±0.4t 5.6±0.5t 4.5±0.3 
Overall SD, mmHg 6.1±0.3 6.8±0.2* 7.5±0.3t 7.7±0.4t 6.3±0.3 
Values are means ± SE (11 = 7 rats). Control represents the last 4 days before stmting SMB infusion. Periods /, 2, and 3 correspond to days 1-4, 5-8, and 
9-12, respectively, of SMB infusion. Recovery corresponds to days 7-10 after cessation of SMB infusion. *P < 0.05 and t P < 0.01 vs. control period 
(Dunnett's). 
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Fig. 4. Effects of a 12-day SMB infusion on the daily 
balance of water, sodium, and potassium. Water intake 
and sodium intake include the amount of water and 
sodium, respectively, contained in the intravenous infu-
sion. Balance was computed as intake minus urinary 
excretion. 
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from bovine carotid artery was verified by radioimmunoassay 
(13). Taken together, these results show that endothelial cells 
can synthesize and release ACh, which may act as an autacoid 
and reinforce stretch-induced nitric oxide (NO) release. Inhi-
bition of endothelial muscarinic receptors by SMB may thus 
impair stretch-induced NO release. Interestingly, the hyperten-
sive effect of NO synthase inhibition is potentiated by acute 
cholinergie blockade (14), suggesting an interaction between 
cholinergie and nitrergic vasodilatation. 
For the third factor, the kidneys may also be involved in the 
SMB increase in BP. Normally, a rapid increase in BP by 
vasoconstrictors would be expected to result in a pressure-
induced natriuresis (10). Yet, no initial natriuresis was ob-
served in our experiments despite a rise in BP of more than 10 
mmHg, suggesting sodium-retaining forces that could offset 
pressure-induced natriuresis. ACh has a natriuretic effect on 
the kidney, which is inhibited by atropine (34). Although there 
is no clear parasympathetic innervation of the kidneys (5), the 
antagonism of endothelial mechanisms, as described above, 
could possibly promote renal vasoconstriction and sodium 
retenti on. 
Finally, ACh is known to inhibit the release of norepineph-
rine from sympathetic nerve terminais via stimulation of 
prejunctional muscarinic receptors (36). Thus an additional 
possibility is that blockade of these receptors by SMB could 
effectively increased sympathetic tone at the level of the heart 
and vasculature. 
Although a chronic increase in 24 h BP of 3-6% is physi-
ologically relatively modest, human clinical trials indicate that 
sustained similar increases in BP would have substantial ef-
fects on cardiovascular risk. Furthermore, it is possible that the 
tonie influence of the parasympathetic nervous system on BP 
may play a larger role in humans or in other circumstances. 
Indeed, rats have a modest parasympathetic tone compared 
with larger animais such as dogs and humans, perhaps in part 
because they are usually studied at laboratory temperatures 
( ~20-22°C), which are well below the range of ambient 
temperatures that requires minimal thermoregulatory effort to 
maintain body temperature (thermoneutrality zone). The ther-
mal neutral zone of healthy rats of common strains in experi-
mental setups similar to ours (single cage housing, no bedding) 
is around 30°C (23). Warming ambient temperature into the 
zone of thermoneutrality has been shown to reduce BP and HR 
and to increase HR variability in both rats and mice (28). The 
parasympathetic system may thus play a potential larger role in 
BP regulation in humans than in rats and mice maintained at 
standard laboratory temperatures. 
Chronic muscarinic blockade also led to significant increases 
in short-term (within 30 min SD), long-term (between 30 min 
SD), and overall (22 h SD) BPV. Vagal dysfonction impairs 
the baroreflex contrai of HR, which in turn could lead to 
greater oscillations in BP and hence to an increased short-term 
BPV (7). Indeed, muscarinic blockade in our study led to a 
marked and sustained decrease in "short-term" HR variability 
and an increase in short-term BPV. The slow increase in 
long-term BPV observed during SMB infusion is intriguing, 
but the underlying mechanism remains unclear. 
Increases in BPV could contribute to hypertensi ve target 
organ damage (TOD). lndeed, several clinical investigations 
have found TOD to be more advanced in patients with in-
creased BPV (19, 21). These findings have been reinforced by 
a prospective investigation (9) in which patients that had taken 
part in one of the original studies (19) were followed up ~7 
years later. The role of systolic BPV in promoting TOD has 
been confirmed in large clinical studies, such as the Pressioni 
Arteriose Monitorate E Loro Associazioni (P AMBLA) study 
(25) and the Syst-Eur trial (22). 
Perspectives. Parasympathetic dysfonction is not a rare 
event. In addition to hypertension itself, reductions in cardiac 
parasympathetic tone or reactivity have been described in 
obesity (1, 31), diabetes mellitus (3), chronic renal failure (2), 
physical inactivity (24), and ageing (27). Other factors may 
promote parasympathetic dysfonction via direct muscarinic 
receptor inhibition. Autoantibodies against muscarinic recep-
tor, of which its occurrence increases with age, have been 
found in healthy subjects ( 15). Moreover, some major drugs, 
such as neuroleptics, antiarrhythmics, and antidepressants may 
have anticholinergic effects. 
Whereas a contribution of parasympathetic dysfonction to 
cardiovascular morbidity has been suggested by many authors, 
the hemodynamic effects of chronic muscarinic blockade have 
not been reported. Our study shows that chronic muscarinic 
receptor inhibition favors a small increase in BP and leads to a 
significant increase in both short-term and long-term BPV. Our 
data suggest that chronic peripheral muscarinic blockade could 
contribute to the development or aggravation of hypertension 
and TOD. 
ACKNOWLEDGMENTS 
The authors thank Aldo Tempini for expert technical assistance. 
REFERENCES 
1. Arone LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J. Auto-
nomie nervous system activity in weight gain and weight loss. Am J 
Physiol Regu/ lntegr Comp Physio/ 269: R222-R225, 1995. 
2. Axelrod S, Lishuer M, Oz O, Bernheim J, Ravid M. Spectral analysis 
of fluctuations in heart rate: an objective evaluation of autonomie nervous 
control in chronic renal failure. Neplmm 45: 202-206, 1987. 
3. Barron SA, Rogovski Z, Kantcr Y, Hemli Y. Parasympathetic auto-
nomie neuropathy in diabetes mellitus: the heart is denervated more often 
than the pupil. Electmmyogr Clin Neurophysiol 34: 467-469, 1994. 
4. Brown JH, Taylo1· P. Muscarinic receptor agonists and antagonists. 
ln: Goodman and Gilman 's Pharmacological Basis of Therapeutics, 
edited by Hardman JG and Limbird LE. New York: McGraw-Hill, 
2001, p. 155-173. 
5. DiBona GF, Kopp UC. Neural control of renal fonction. Physiol Rev 77: 
75-197, 1997. 
6. Ester M. The sympathetic system and hypertension. Am J Hypertens 13: 
99S-105S, 2000. 
7. Ferrari AU, Franzelli C, Daffonchio A, Perlini S, Diricnzo M. Sym-
pathovagal interplay in the control of overall blood pressure variability in 
unanesthetized rats. Am J Physio/ Heart Circ Physiol 270: H2143-H2148, 
1996. 
8. Fisher SJ, Scher AM, Wyss CR. Long-tenn responses of atrial rate and 
peripheral resistance to changes in ventricular pacing rate in awake dogs 
with atrioventricular block. Circ Res 54: 196-203, 1984. 
9. Frattola A, Parati G, Cuspidi C, Albini F, Manda G. Prognostic value 
of 24-hour blood pressure variability. J Hypertens 11: 1133-1137, 1993. 
10. Hall JE, Mizelle HL, Woods LL, Montani JP. Pressure natriuresis and 
control of mterial pressure during chronic norepinephrine infusion. J Hy-
pertens 6: 723-731, 1988. 
11. Ikeda C, Morita 1, Mori A, Fujimoto K, Suzuki T, Kawashima K, 
Murota S. Phorbol ester stimulates acetylcholine synthesis in cultured 
endothelial cells isolated from porcine cerebral microvessels. Brain Res 
655: 147-152, 1994. 
12. Julius S, Pascual A V, London R. Role of parasympathetic inhibition in 
the hyperkinetic type of borderline hypertension. Circulation 44: 413-
418, 1971. 
AJP-Heart Circ Plzysiol •VOL 293 • SEPTEMBER 2007 • www.ajphemt.org 
1 tapraid4/zh4-ahea/zh4-ahea/zh400907/zh47663d07a I tillotsj 1 8=3 1 6/19/07 I 8:32 1 MS: H-00326-2007 l ini: 09/km/ss 1 
H8 BLOOD PRESSURE AND CHRONIC PARASYMPATHETIC BLOCKADE 
13. Kawashima K, Watanabe N, Oohata H, Fujimoto K, Suzuki T, 
Ishizaki Y, Morita I, Murota S. Synthesis and release of acetylcholine by 
cultured bovine arterial endothelial cells. Neurosci Leff 119: 156-158, 
1990. 
14. Lepori M, Sartori C, Duplain H, Nicod P, Scherrer U. Interaction 
between cholinergie and nitrergic vasodilation: a nove! mechanism of 
blond pressure control. Cardiovasc Res 51: 767-772, 2001. 
15. Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML. Screening of serum 
autoantibodies to cardiac beta 1-adrenoceptors and M2-muscarinic acetyl-
choline receptors in 408 healthy subjects of varying ages. A11toimm1111ity 
29: 43-51, 1999. 
16. Milner P, Kirkpatrick KA, Ralevic V, Toothill V, Pearson J, Burn-
stock G. Endothelial cells cultured from human umbilical vein release 
A TP, substance P and acetylcholine in response to increased flow. Proc R 
Soc Lond B Bio/ Sei 241: 245-248, 1990. 
17. Montani JP, Mizelle HL, Van Vliet BN, Adah· TH. Advantages of 
continuous measurement of cardiac output 24 ha day. Am J Physiol Heart 
Circ Physiol 269: H696-H703, 1995. 
18. Montano N, Cogliati C, Porta A, Pagani M, Malliani A, Narkiewicz K, 
Abboud FM, Birkett C, Somers VK. Central vagotonie effects of 
atropine modulate spectral oscillations of sympathetic nerve activity. 
Circulation 98: 1394-1399, 1998. 
19. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship 
of 24-hour blond pressure mean and variability to severity of target-organ 
damage in hype1tension. J Hypertens 5: 93-98, 1987. 
20. Parnavelas JG, Kelly W, Burnstock G. Ultrastructural localization of 
choline acetyltransferase in vascular endothelial cells in rat brain. Nature 
316: 724-725, 1985. 
21. Pessina AC, Palatini P, Sperti G, Cordoue L, Libardoni M, Mos L, 
Mormino P, Di Marco A, Dai Palu C. Evaluation of hypeitension and 
related target organ damage by average day-time blood pressure. Clin Exp 
Hypertens 7: 267-278, 1985. 
22. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, De Leeuw 
PW, Jaaskivi M, Nachev C, Parati G, O'Brien ET, Tuomilehto J, 
Webster J, Bulpitt CJ, Fagard RH. Systolic blood pressure variability as 
a risk factor for stroke and cardiovascular mortality in the elderly hyper-
tensive population. J Hypertens 21: 2251-2257, 2003. 
23. Romanovsky AA, Ivanov AI, Shimansky YP. Selected contribution: 
ambient temperature for experiments in rats: a new method for determin-
ing the zone of thermal neutrality. J Appl Physio/ 92: 2667-2679, 2002. 
24. Seals DR, Chase PB. Influence of physical training on heart rate vari-
ability and baroreflex circulatory control. J Appl Physiol 66: 1886-1895, 
1989. 
25. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, 
Ferrario M, Mancia G. Blond pressure variability and organ damage in 
a general population: results from the PAMELA study (Pressioni Arteriose 
Monitorate E Loro Associazioni). Hypertension 39: 710-714, 2002. 
26. Stefanadis C, Dernellis J, Vavuranakis M, Tsiamis E, Vlachopoulos C, 
Toutouzas K, Diamandopoulos L, Pitsavos C, Toutouzas P. Effects of 
ventricular pacing-induced tachycardia on aortic mechanics in man. Car-
diovasc Res 39: 506-514, 1998. 
27. Stratton JR, Levy WC, Caldwell JH, .Jacobson A, May J, Matsuoka D, 
Madden K. Effects of aging on cardiovascular responses to parasympa-
thetic withdrawal. J Am Coll Cardio/ 41: 2077-2083, 2003. 
28. Swoap S.J, Overton JM, Garber G. Effect of ambient temperature on 
cardiovascular parameters in rats and mice: a comparative approach. Am J 
Physio/ Reg11/ lntegr Comp Physiol 287: R391-R396, 2004. 
29. Van Vliet BN, Chafe LL, Antic V, Schnyder-Candrian S, Montani JP. 
Direct and indirect methods used to study mterial blond pressure. J Plwr-
maco/ Toxico/ Metlwds 44: 361-373, 2000. 
30. Van Vliet BN, Chafe LL, Montani JP. Contribution of baroreceptors and 
chemoreceptors to ventricular hype11rophy produced by sino-aortic dener-
vation in rats. J Physio/ 516: 885-895, 1999. 
31. Van Vliet BN, Hall JE, Mizelle HL, Montani JP, Smith M.J .Jr, 
Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol 
Heart Circ Physiol 269: H629-H637, 1995. 
32. Van Vliet BN, Hu L, Scott T, Chaf'e L, Montani .JP. Cardiac hypertro-
phy and telemetered blood pressure 6 wk after baroreceptor denervation in 
normotensive rats. Am J Physiol Regu/ lntegr Comp Physiol 271: Rl 759-
R1769, 1996. 
33. van Zwieten PA, Hendriks MG, Pfaffendorf M, Brnning TA, Chang 
PC. The parasympathetic system and its muscarinic receptors in hyper-
tensive diseuse. J Hypertens 13: I079-I090, 1995. 
34. Vander AJ. Effects of Acetylcholine, Atropine, and Physostigmine on 
Rena! Fonction in the Dog. Am J Physio/ 206: 492-498, 1964. 
35. Wang .J, Tempini A, Schnyder B, Montani .JP, Regulation of blond 
pressure during long-tenn ouabain infusion in Long-Evans rats. A111 J 
Hypertens 12: 423-426, 1999. 
36. Zhang JX, Okamura T, Toda N. Prejunctional regulation by endogenous 
and exogenous acetylcholine of adrenergic nerve function in isolated 
canine mesenteric mteries. Hypertens Res 20: 119-125, 1997. 
AJP-Heart Circ Physiol •VOL 293 • SEPTEMBER 2007 • www.ajphemt.org 
